Publications
812
Citations
21,307
Est. group size
~6
Recurring co-author estimate
Active years
32
Publishing since 1995
Shannon L. Risacher studies Alzheimer's disease and related dementias, focusing on brain imaging (neuroimaging) and biomarkers that can detect and track the disease before and during its progression. The research combines imaging, genetics, and blood-based markers to understand cognitive decline, and explores factors such as sex differences, vascular risk, and sensory changes. This work aims to improve early detection and characterization of patients, including in the era of new anti-amyloid therapies.
Publication activity was high in the late 2010s (around 80 per year), dipped notably in 2020-2021, then partially rebounded, averaging about 35 per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2026
- Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies
Alzheimer s & Dementia · 2025
- Evaluation of an in vivo biomarker of arteriolosclerosis (ARTS) and its associations with cognition and multimodal ATN(V) biomarkers in a cardiometabolic-risk enriched community cohort
medRxiv · 2025
- Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease
Journal of Alzheimer s Disease · 2025
- Neuroimaging in Dementia
CONTINUUM Lifelong Learning in Neurology · 2024
- Mutation ∆K281 in MAPT causes Pick’s disease
Acta Neuropathologica · 2023
- Sexual dimorphisms in longitudinal associations of the blood lipidome with cognitive decline in Alzheimer’s disease
Alzheimer s & Dementia · 2023
- CEREBROVASCULAR DAMAGE IN COVID-19 ICU SURVIVORS
CHEST Journal · 2023
- Sex differences in plasma p‐tau181 accumulation is associated with subsequent tau‐PET signal
Alzheimer s & Dementia · 2023
- Model‐EyeD: Harnessing the potential of the eye as a biomarker for Alzheimer’s disease and related dementias
Alzheimer s & Dementia · 2023
- Neuroimaging in Dementia
CONTINUUM Lifelong Learning in Neurology · 2023
- Biomarkers for dementia in Latin American countries: Gaps and opportunities
Alzheimer s & Dementia · 2022
- Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning
Molecular Psychiatry · 2022
- Associations between Cortical Thickness and Metamemory in Alzheimer’s Disease
Brain Imaging and Behavior · 2022
- Deep Fusion of Brain Structure-Function in Mild Cognitive Impairment
Medical Image Analysis · 2021
- Alzheimer s & Dementia×263
- PMC×23
- Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring×17
- medRxiv×17
- bioRxiv (Cold Spring Harbor Laboratory)×12
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile